annual operating profit:
-$145.85M-$70.79M(-94.30%)Summary
- As of today (June 17, 2025), EYPT annual operating income is -$145.85 million, with the most recent change of -$70.79 million (-94.30%) on December 31, 2024.
- During the last 3 years, EYPT annual operating profit has fallen by -$90.58 million (-163.86%).
- EYPT annual operating profit is now -1704.38% below its all-time high of $9.09 million, reached on June 30, 2010.
Performance
EYPT Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$48.84M-$3.60M(-7.95%)Summary
- As of today (June 17, 2025), EYPT quarterly operating income is -$48.84 million, with the most recent change of -$3.60 million (-7.95%) on March 31, 2025.
- Over the past year, EYPT quarterly operating profit has dropped by -$15.52 million (-46.57%).
- EYPT quarterly operating profit is now -334.92% below its all-time high of $20.79 million, reached on September 30, 2014.
Performance
EYPT quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$161.37M-$15.52M(-10.64%)Summary
- As of today (June 17, 2025), EYPT TTM operating income is -$161.37 million, with the most recent change of -$15.52 million (-10.64%) on March 31, 2025.
- Over the past year, EYPT TTM operating profit has dropped by -$74.54 million (-85.84%).
- EYPT TTM operating profit is now -1575.18% below its all-time high of $10.94 million, reached on September 30, 2014.
Performance
EYPT TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
EYPT Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.3% | -46.6% | -85.8% |
| 3 y3 years | -163.9% | -167.1% | -157.7% |
| 5 y5 years | -204.7% | -326.8% | -261.4% |
EYPT Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -163.9% | at low | -239.2% | at low | -157.7% | at low |
| 5 y | 5-year | -291.1% | at low | -2395.5% | at low | -381.2% | at low |
| alltime | all time | -1704.4% | at low | -334.9% | at low | -1575.2% | at low |
EYPT Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$48.84M(+8.0%) | -$161.37M(+10.6%) |
| Dec 2024 | -$145.85M(+94.3%) | -$45.24M(+38.1%) | -$145.85M(+24.7%) |
| Sep 2024 | - | -$32.75M(-5.2%) | -$116.97M(+18.6%) |
| Jun 2024 | - | -$34.55M(+3.7%) | -$98.62M(+13.6%) |
| Mar 2024 | - | -$33.32M(+103.7%) | -$86.83M(+15.7%) |
| Dec 2023 | -$75.07M(-4.9%) | -$16.35M(+13.6%) | -$75.07M(-8.2%) |
| Sep 2023 | - | -$14.40M(-36.7%) | -$81.75M(-4.7%) |
| Jun 2023 | - | -$22.76M(+5.6%) | -$85.75M(+4.3%) |
| Mar 2023 | - | -$21.55M(-6.4%) | -$82.20M(+4.1%) |
| Dec 2022 | -$78.94M(+42.8%) | -$23.04M(+25.2%) | -$78.93M(+6.7%) |
| Sep 2022 | - | -$18.40M(-4.3%) | -$73.95M(+4.4%) |
| Jun 2022 | - | -$19.22M(+5.1%) | -$70.86M(+13.2%) |
| Mar 2022 | - | -$18.28M(+1.3%) | -$62.63M(+13.3%) |
| Dec 2021 | -$55.28M(+48.2%) | -$18.05M(+17.9%) | -$55.28M(+10.6%) |
| Sep 2021 | - | -$15.31M(+39.5%) | -$49.96M(+36.5%) |
| Jun 2021 | - | -$10.98M(+0.4%) | -$36.61M(-0.5%) |
| Mar 2021 | - | -$10.94M(-14.1%) | -$36.78M(-1.4%) |
| Dec 2020 | -$37.29M(-22.1%) | -$12.74M(+550.8%) | -$37.29M(+11.2%) |
| Sep 2020 | - | -$1.96M(-82.5%) | -$33.54M(-26.5%) |
| Jun 2020 | - | -$11.15M(-2.6%) | -$45.64M(+2.2%) |
| Mar 2020 | - | -$11.44M(+27.4%) | -$44.65M(-6.7%) |
| Dec 2019 | -$47.86M(+94.9%) | -$8.98M(-36.1%) | -$47.86M(+23.1%) |
| Sep 2019 | - | -$14.06M(+38.3%) | -$38.88M(+1.3%) |
| Jun 2019 | - | -$10.16M(-30.6%) | -$38.37M(+1.0%) |
| Mar 2019 | - | -$14.65M(+8.1%) | -$37.99M(+12.3%) |
| Dec 2018 | -$24.56M(-6.5%) | - | - |
| Sep 2018 | - | -$13.55M(+38.6%) | -$33.82M(+28.7%) |
| Jun 2018 | -$26.27M(+41.4%) | -$9.78M(+109.1%) | -$26.27M(+16.1%) |
| Mar 2018 | - | -$4.68M(-19.5%) | -$22.63M(-2.1%) |
| Dec 2017 | - | -$5.81M(-3.3%) | -$23.11M(+32.8%) |
| Sep 2017 | - | -$6.01M(-2.1%) | -$17.40M(-6.4%) |
| Jun 2017 | -$18.58M(-14.7%) | -$6.14M(+18.9%) | -$18.58M(-1.7%) |
| Mar 2017 | - | -$5.16M(+5389.4%) | -$18.90M(+0.3%) |
| Dec 2016 | - | -$94.00K(-98.7%) | -$18.83M(-21.5%) |
| Sep 2016 | - | -$7.19M(+11.3%) | -$23.98M(+10.1%) |
| Jun 2016 | -$21.77M(-439.1%) | -$6.46M(+26.7%) | -$21.77M(+6.1%) |
| Mar 2016 | - | -$5.10M(-2.7%) | -$20.52M(+0.2%) |
| Dec 2015 | - | -$5.24M(+5.1%) | -$20.47M(+5.8%) |
| Sep 2015 | - | -$4.98M(-4.2%) | -$19.35M(-401.4%) |
| Jun 2015 | $6.42M(-147.3%) | -$5.20M(+2.9%) | $6.42M(-15.6%) |
| Mar 2015 | - | -$5.05M(+22.7%) | $7.61M(-27.1%) |
| Dec 2014 | - | -$4.12M(-119.8%) | $10.44M(-4.6%) |
| Sep 2014 | - | $20.79M(-617.9%) | $10.94M(-180.6%) |
| Jun 2014 | -$13.57M | -$4.01M(+80.6%) | -$13.57M(+0.2%) |
| Mar 2014 | - | -$2.22M(-38.5%) | -$13.54M(-4.2%) |
| Dec 2013 | - | -$3.61M(-2.8%) | -$14.12M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$3.72M(-6.6%) | -$13.16M(+9.4%) |
| Jun 2013 | -$12.03M(+15.9%) | -$3.98M(+41.6%) | -$12.03M(+16.1%) |
| Mar 2013 | - | -$2.81M(+6.2%) | -$10.36M(+0.8%) |
| Dec 2012 | - | -$2.65M(+2.2%) | -$10.28M(-1.6%) |
| Sep 2012 | - | -$2.59M(+12.1%) | -$10.44M(+0.6%) |
| Jun 2012 | -$10.38M(+3.8%) | -$2.31M(-15.3%) | -$10.38M(+23.9%) |
| Mar 2012 | - | -$2.73M(-3.1%) | -$8.38M(-4.7%) |
| Dec 2011 | - | -$2.81M(+11.1%) | -$8.79M(-3.4%) |
| Sep 2011 | - | -$2.53M(+721.8%) | -$9.10M(-9.0%) |
| Jun 2011 | -$10.00M(-210.0%) | -$308.00K(-90.2%) | -$10.00M(-503.5%) |
| Mar 2011 | - | -$3.14M(+0.6%) | $2.48M(-10.0%) |
| Dec 2010 | - | -$3.12M(-9.1%) | $2.75M(-52.2%) |
| Sep 2010 | - | -$3.44M(-128.2%) | $5.76M(-36.6%) |
| Jun 2010 | $9.09M(-296.1%) | $12.17M(-525.2%) | $9.09M(-389.7%) |
| Mar 2010 | - | -$2.86M(+2433.6%) | -$3.14M(+197.2%) |
| Dec 2009 | - | -$113.00K(+5.6%) | -$1.06M(-55.3%) |
| Sep 2009 | - | -$107.00K(+94.5%) | -$2.36M(-49.0%) |
| Jun 2009 | -$4.64M(-81.4%) | -$55.00K(-93.0%) | -$4.64M(-51.8%) |
| Mar 2009 | - | -$781.00K(-45.0%) | -$9.62M(-37.7%) |
| Dec 2008 | - | -$1.42M(-40.3%) | -$15.45M(-30.0%) |
| Sep 2008 | - | -$2.38M(-52.8%) | -$22.07M(-11.4%) |
| Jun 2008 | -$24.90M(-29.9%) | -$5.04M(-23.7%) | -$24.90M(-56.5%) |
| Mar 2008 | - | -$6.61M(-17.8%) | -$57.18M(+13.2%) |
| Dec 2007 | - | -$8.04M(+54.2%) | -$50.51M(-0.9%) |
| Sep 2007 | - | -$5.21M(-86.0%) | -$50.97M(+13.4%) |
| Jun 2007 | -$35.54M(+28.4%) | -$37.32M(<-9900.0%) | -$44.97M(+23.6%) |
| Mar 2007 | - | $65.00K(-100.8%) | -$36.38M(+0.8%) |
| Dec 2006 | - | -$8.50M(-1175.4%) | -$36.09M(+34.1%) |
| Sep 2006 | - | $790.40K(-102.8%) | -$26.92M(-1.5%) |
| Jun 2006 | -$27.68M(+90.2%) | -$28.73M(-8264.7%) | -$27.33M(+100.5%) |
| Mar 2006 | - | $351.90K(-47.5%) | -$13.63M(-1.4%) |
| Dec 2005 | - | $670.70K(+78.8%) | -$13.82M(-3.6%) |
| Sep 2005 | - | $375.10K(-102.5%) | -$14.33M(-1.5%) |
| Jun 2005 | -$14.55M(+133.3%) | -$15.03M(-9470.5%) | -$14.56M(+143.3%) |
| Mar 2005 | - | $160.40K(-0.9%) | -$5.98M(-1.4%) |
| Dec 2004 | - | $161.80K(+7.4%) | -$6.07M(-1.5%) |
| Sep 2004 | - | $150.70K(-102.3%) | -$6.16M(-1.4%) |
| Jun 2004 | -$6.24M(+73.4%) | -$6.46M(-8954.7%) | -$6.25M(+81.7%) |
| Mar 2004 | - | $72.90K(+1.5%) | -$3.44M(-1.6%) |
| Dec 2003 | - | $71.80K(+10.6%) | -$3.49M(-1.6%) |
| Sep 2003 | - | $64.90K(-101.8%) | -$3.55M(-1.4%) |
| Jun 2003 | -$3.60M(+181.3%) | -$3.65M(<-9900.0%) | -$3.60M(-7728.4%) |
| Mar 2003 | - | $16.70K(+7.7%) | $47.20K(+54.8%) |
| Dec 2002 | - | $15.50K(+3.3%) | $30.50K(+103.3%) |
| Sep 2002 | - | $15.00K | $15.00K |
| Jun 2002 | -$1.28M(+194.2%) | - | - |
| Jun 2001 | -$434.60K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual operating profit year-on-year change?
- What is EyePoint Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly operating profit year-on-year change?
- What is EyePoint Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM operating profit year-on-year change?
What is EyePoint Pharmaceuticals annual operating income?
The current annual operating profit of EYPT is -$145.85M
What is the all time high annual operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual operating income is $9.09M
What is EyePoint Pharmaceuticals annual operating profit year-on-year change?
Over the past year, EYPT annual operating income has changed by -$70.79M (-94.30%)
What is EyePoint Pharmaceuticals quarterly operating income?
The current quarterly operating profit of EYPT is -$48.84M
What is the all time high quarterly operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly operating income is $20.79M
What is EyePoint Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, EYPT quarterly operating income has changed by -$15.52M (-46.57%)
What is EyePoint Pharmaceuticals TTM operating income?
The current TTM operating profit of EYPT is -$161.37M
What is the all time high TTM operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM operating income is $10.94M
What is EyePoint Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, EYPT TTM operating income has changed by -$74.54M (-85.84%)